Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Angiogenesis has always been the topic of major scientific interest in the field of malignant tumors. Nowadays, targeting angiogenesis has achieved success in various carcinomas by several mechanisms, including the use of anti-angiogenic small molecule receptor tyrosine kinase inhibitors (TKIs). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Shuang, Li, Anping, Yi, Ming, Yu, Shengnan, Zhang, Mingsheng, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417086/
https://www.ncbi.nlm.nih.gov/pubmed/30866992
http://dx.doi.org/10.1186/s13045-019-0718-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417086/
https://www.ncbi.nlm.nih.gov/pubmed/30866992
http://dx.doi.org/10.1186/s13045-019-0718-5

Ejemplares similares